DreamPharm Products:
Lutein-20||Herbs for headache, fever, and migraine ||
Milk thistle||Saw palmetto||
Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract||
Ginseng and Ginkgo||Hair Million||
DHEA||Coenzyme Q10||
Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.||
Weight loss herbal formula for menopause and pms||Ginkgo biloba||
Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver
Fatty acids resources:
Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 ||
Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5
Metabolism. 2002 Nov;51(11):1423-6.
Circulating brain natriuretic peptide values in healthy men before and after exercise.
Huang WS, Lee MS, Perng HW, Yang SP, Kuo SW, Chang HD.
Department of Nuclear Medicine, Tri-Service General Hospital, Taipei, Taiwan, ROC.
Circulating brain natriuretic peptide (BNP) has recently served as a marker of left ventricular dysfunction, while treadmill exercise has been used clinically for assessing cardiac problems. The current study was undertaken to investigate the possible effect of exercise on circulating BNP concentrations. A total of 138 blood samples from 23 healthy men aged 23 to 27 years (mean, 25) was analyzed. All subjects maintained a similar diet and physical activity a week before the test. Plasma samples were drawn at baseline and immediately, 1 hour, 4 hours, 24 hours, and 48 hours after exercise. Every subject completed exercise according to the Bruce protocol with normal electrocardiogram (EKG) results. Specimens were simultaneously analyzed for concentrations of plasma BNP and other biochemical parameters including aldosterone (Aldo), adrenocorticotropic hormone (ACTH), cortisol, creatine phosphokinase (CPK), triiodothyronine (T(3)), and thyroxine (T(4)). Hematocrit (Hct), red blood cell count (RBC), and hemoglobin (Hgb) were analyzed immediately after each sampling. A transient increase in plasma BNP was found immediately after exercise (8.21 v baseline value, 3.38 pg/mL, P <.01). Twenty-two percent (5/23 subjects) had values above the normal limit (18.2 pg/mL). The Hct-corrected concentrations of plasma BNP were also significantly increased immediately after exercise compared with the baseline values (0.17 +/- 0.04 v baseline, 0.07 +/- 0.01, P <.01), but returned rapidly to baseline. Weak, but significantly positive, relationships were found between plasma BNP and T(3) and T(4). Our study demonstrates that circulating BNP values increase immediately after treadmill exercise in young adults. The elevation did not result from exercise-induced hemoconcentration. BNP concentration, however, returned to normal levels within 1 hour after exercise. Thus, we suggest that plasma samples should not be taken immediately after exercise to avoid possible artifacts. 2002, Elsevier Science (USA). All rights reserved.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12404192&dopt=Abstract
Metabolism. 2002 Nov;51(11):1489-93.
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.
Kokkotou E, Marafelia P, Mantzos EI, Tritos NA.
Joslin Diabetes Center, Boston, MA 02215, USA.
Chemokines are a large family of cytokines, which may be involved in the pathogenesis of a wide variety of inflammatory or autoimmune conditions. The role of chemokines in chronic autoimmune thyroiditis is unknown. We sought to examine the role of CC chemokines in chronic autoimmune thyroiditis. We measured serum levels of CC chemokines, including monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein 1a and 1b (MIP-1a and MIP-1b) in 32 women with chronic autoimmune thyroiditis in comparison with 2 control groups (33 apparently healthy women and 43 women with benign cold thyroid nodules) by enzyme-linked immunosorbent assay (ELISA). We found a 45% increase in serum MCP-1 levels in women with chronic autoimmune thyroiditis compared with either of the 2 control groups (P =.01). There was no difference in either serum MIP-1a (P =.69) or MIP-1b (P =.81) levels between women with chronic autoimmune thyroiditis and controls. Among women with chronic autoimmune thyroiditis, women with a family history of hypothyroidism had a 59% increase in serum MCP-1 levels compared with women with no family history of hypothyroidism (P =.02). Serum MCP-1 levels were associated with serum levels of antithyroid peroxidase (r =.2, P =.03) (anti-TPO Ab) and antithyroglobulin (r =.2, P =.04) antibodies (anti-TG Ab). There was no association between serum MCP-1 levels and serum free thyroxine index (P =.57), triiodothyronine (T(3)) (P =.47) or thyroid-stimulating hormone (TSH) (P =.47) levels. Serum MCP-1 is increased in women with chronic autoimmune thyroiditis, especially in the presence of a family history of hypothyroidism, indicating a possible pathogenetic role for MCP-1 in this condition. 2002, Elsevier Science (USA). All rights reserved.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12404203&dopt=Abstract
Metabolism. 2002 Nov;51(11):1514-8.
Differences in the lipolytic function of adipose tissue preparations from Black American and Caucasian women.
Barakat H, Hickner RC, Privette J, Bower J, Hao E, Udupi V, Green A, Pories W, MacDonald K.
Department of Biochemistry, East Carolina University, Greenville, NC 27858, USA.
The purpose of this study was to determine the potential causes of the lower lipolytic rates in obese Black American women compared to obese Caucasian women. Subcutaneous and omental adipose tissue were obtained from subjects during abdominal surgery, and hormone-sensitive lipase (HSL) mass, mRNA, and activity were determined. HSL mRNA levels did not differ between the Black American and Caucasian women in either subcutaneous or omental adipose tissue. However, HSL mass was approximately 35% lower (P <.05) in both subcutaneous and omental adipose tissue of the Black Americans. Because of these differences, we measured HSL activity in frozen subcutaneous and omental adipose tissue, and also measured basal and isoproterenol-stimulated lipolytic rates in tissue fragments. No racial differences were found in the activity of HSL in either subcutaneous or omental adipose tissue. However, basal lipolytic rates in the Black Americans were 53% and 44% lower (P <.05) in the subcutaneous and omental fat, respectively, compared to the Caucasian women, despite a lack of difference in cell size between the 2 groups. Interestingly, the degree of stimulation by isoproterenol was higher in both the subcutaneous and omental adipose tissue of the Black American than those of the Caucasian women, resulting in equal stimulation by isoproterenol in the 2 groups. These results indicate that despite the lower mass and lower basal HSL activity in the obese Black American women, stimulation of HSL results in equal activity of the enzyme in the 2 races. This suggests that the signaling pathway of HSL stimulation is more efficient in the Black American women. 2002, Elsevier Science (USA). All rights reserved.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12404207&dopt=Abstract
Hum Psychopharmacol. 2000 Aug;15(6):429-438.
Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment.
Conca A, Swoboda E, Konig P, Koppi S, Beraus W, Kunz A, Fritzsche H, Weiss P.
Department of Psychiatry I, Regional Hospital Rankweil, 6830 Rankweil, Austria.
Research on single and rapid transcranial magnetic stimulation (sTMS/rTMS) indicates an antidepressive efficacy of these methods. In our 4 week study of sTMS, 12 patients affected by severe non-psychotic major depression (DSM-III-R) were enrolled and put on standardized combined antidepressant medication with the serotonin re-uptake inhibitor citalopram, and the serotonin modulating drug, trazodone. They underwent sTMS in a specific method as an add-on therapy. Age, gender, illness and episode duration, episode number, Hamilton Rating Depression Scale-24 (HRDS), Mini-Mental State (MMS), drug levels assessed by HPLC, magnesium and thyroid stimulating hormone (TSH) were recorded. For each patient functional brain imaging was performed by (18)FDG and (99m)Tc HMPAO SPECT at the beginning of the study, as were EEG tracings which also were recorded at the end. Lorazepam was allowed as co-medication. Of the patients, 66.7 per cent (N=8) could be identified as sTMS responders. Possible predictors for sTMS response as add-on therapy may be duration, pattern of improvement in global and in specific single items of the HRDS, lorazepam dosage, functional involvement of basal ganglia and cortical temporal lobe and the initially lower mean frequency and lability of the alpha-activity of EEG. These variables possibly predict the clinical outcome of depressed patients treated by sTMS as an add-on therapy. 2000 John Wiley & Sons, Ltd.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12404305&dopt=Abstract [PubMed - as supplied by publisher]
Hum Psychopharmacol. 2000 Jul;15(5):337-345.
Sexual dysfunction in depression.
Michael A, O'Keane V.
Department of Psychiatry, West Suffolk Hospital, Bury St Edmunds, IP33 2QZ, UK.
Sexual dysfunction is a well-known symptom of depression. However, it has received little, if any, attention from clinicians and researchers. A review of published literature suggests that sexual dysfunction occurs in the majority of depressed patients. It has a major impact on the quality of life of the patients. The pathophysiology of sexual dysfunction in depression involves a complex interplay of various neurotransmitters and hormones. Clinicians need to be more proactive in enquiring about sexual dysfunction in depressed patients. More information is needed about the nature, prevalence and pathophysiology of sexual dysfunction in depression. 2000 John Wiley & Sons, Ltd.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12404311&dopt=Abstract [PubMed - as supplied by publisher]
Hair loss is genetically influenced, but it is always difficult to predict. Overall, more than 50% of US men suffer hair loss by their age of 45. Men are more likely to lose hair than women. Hair Million offers an alternative solution to hair loss problems. Anecdotal evidence and personal experiences indicate the efficacy of this herbal blend in improveming age-related hair thinning and hair loss for a number of people who take it. The mechanism of action as to how Hair Million works to help stop hair loss, and promote hair growth is totally unknown. It is only known by anecdotal observations. There has been no clinical trials nor placebo controlled statistical analysis on the efficacy of Hair Million on hair loss and hair growth. Propecia is a clinically tested drug for the purpose of reversing hair loss.
DHEA is a natural hormone, and it is produced in our body by the adrenal glands.
DHEA has been suggested to provide numerous potential benefits. DHEA (or dehydroepiandrosterone) is converted into androgens (male hormones)
or estrogens (female hormones) in the cells.
Our bodies produce decreasing amount of DHEA as we get older.
various health benefits: To deter aging,
improve sexual function/erectile dysfunction, treat cognitive decline, enhance athletic performance,
facilitate weight loss, improve strength, prevent osteoporosis, enhance immunomodulation for rheumatic conditions,
and treat depression.
DreamPharm Online Healthy Supplements ||
Constipation relief, laxative, colon cleansing ||
Lutein ||
Progesterone Cream ||
Natural herbal formula for hair loss problems ||